As patent cliff levels off, biosimilars offer opportunity

09/11/2013 | Drug Store News

About $86 billion worth of branded drugs will lose patent protection between 2013 and 2017, compared with $101 billion worth of drugs that lost patent protection between 2008 and 2012, according to IMS. Biologic drugs losing patent protection may present an opportunity for other drugmakers to gain market share, but some U.S. states have passed laws restricting substitution of biosimilar drugs.

View Full Article in:

Drug Store News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA